NCT04297917View on ClinicalTrials.gov

First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

February 10, 2019

Primary Completion Date

May 23, 2022

Study Completion Date

June 26, 2022

Conditions
Hepatitis BHealthy
Interventions
BIOLOGICAL

ChAdOx1-HBV

chimpanzee adenovirus-vectored hepatitis B virus vaccine

Trial Locations (4)

SO16 6YD

University Hospital Southampton NHS Foundation Trust, Southampton

OX3 9DU

Oxford University Hospitals Nhs Foundation Trust, Oxford

OX3 7LE

Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Headington

M23 9QZ

Medicines Evaluations Unit, Manchester

Sponsors
All Listed Sponsors
lead

Barinthus Biotherapeutics

INDUSTRY